Atlas Trials

Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects

Clinical trial NCT02313103 · COMPLETED

Trial details

NCT number
NCT02313103
Sponsor
USWM, LLC (dba US WorldMeds)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renally Impaired Subjects
Start date
2014-11-01
Primary completion
2015-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.